Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $487.17 +0.55 (0.11%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $487.17 +0.55 (0.11%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Apple Reports: Global Week Ahead
by John Blank
The FAANG stock Apple (AAPL) is the biggest earnings report I see looming this week.
Abiomed Gets CDSCO Nod for Impella Heart Pumps in India
by Zacks Equity Research
Abiomed's (ABMD) Impella gets regulatory approval in India; prospects in APAC look upbeat.
Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss
by Zacks Equity Research
Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q2.
Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q2
by Zacks Equity Research
Omnicell's (OMCL) second-quarter 2018 performance impresses with year-over-year growth in earnings and revenues.
Zacks.com highlights: Intuitive Surgical, Celanese, Great Southern Bancorp, Mellanox Technologies and Align Technology
by Zacks Equity Research
Zacks.com highlights: Intuitive Surgical, Celanese, Great Southern Bancorp, Mellanox Technologies and Align Technology
5 Top-Ranked Stocks Picked via Driehaus Strategy
by Zacks Equity Research
We have used Driehaus strategy to select the top momentum stocks using the "buy high and sell higher" rule.
Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ISRG) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical
Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Nike (NKE) and Schlumberger (SLB).
Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues
by Zacks Equity Research
Strong performance in the Instruments & Accessories as well as Systems segments drove Intuitive Surgical's (ISRG) top line in Q2.
Intuitive Surgical (ISRG) Loses 0.9% Ahead of Earnings: What To Expect
by Ryan McQueeney
Shares of Intuitive Surgical (ISRG) fell about 0.9% in morning trading Thursday, just hours before the innovative medical equipment maker is set to release its latest quarterly earnings report. Here's what to expect this afternoon.
The 5 Most Spectacular Earnings Charts This Week
by Tracey Ryniec
These stocks are among the hottest on the Street. Can they keep their upward momentum?
Trump's APAC Focus Puts Spotlight on These 3 MedTech Stocks
by Sreyoshi Mukherjee
Despite the trade war upheaval in Asia, some medical device companies stand strong in the APAC region.
Here's Why You Should Hold Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Strong performance by Intuitive Surgical's (ISRG) flagship da Vinci system is a key growth driver. However, the company faces stiff competition in the niche space.
BD Buys TVA Medical, To Provide Minimally Invasive Procedure
by Zacks Equity Research
The acquisition of TVA Medical will enable Becton, Dickinson (BDX) to treat patients with chronic kidney disease through minimally invasive procedures.
Intuitive Surgical's FDA Approval for SureForm to Aid Surgery
by Zacks Equity Research
Intuitive Surgical's (ISRG) SureForm 60 stapler receives FDA approval; strengthens its profile for minimally invasive surgical solutions.
Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day
by Zacks Equity Research
Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day
3 Stocks to Tap the Minimally-Invasive Surgery Market Boom
by Sweta Jaiswal
Consider these three stocks in the rapidly-growing minimally-invasive surgical device market.
Medical Device Firms in Focus on Expanded R&D Scope: 5 Picks
by Zacks Equity Research
The suspension of the Medical Device Tax, the evolution of mechatronics and big data in the MedTech space make some of the stocks lucrative picks for investment.
Walgreens Boots' Retail Pharmacy Strong Despite Several Woes
by Zacks Equity Research
Walgreens Boots' (WBA) consistent sales rise in the Retail Pharmacy International business is encouraging. Moreover, the company steadily gains traction from a slew of strategic deals.
Mechatronics for Healthcare: 3 MedTech Stocks to Bet On
by Nabaparna Bhattacharya
Here we analyze how Medical Mechatronics is creating new opportunities in MedTech for investors who are keen on putting their money in the healthcare space for longer-term gains.
QIAGEN (QGEN) Banks on Molecular Diagnostics, Global Growth
by Zacks Equity Research
QIAGEN's (QGEN) progress with the test menu expansion is impressive. Earlier in Q1, the company also secures the Japanese approval for QuantiFERON-TB Gold Plus as an in vitro diagnostic to detect TB.
Medtronic's Expanded IN.PACT Admiral FDA Nod to Aid APV Arm
by Zacks Equity Research
Medtronic's (MDT) receipt of FDA approval for 200mm and 250mm lengths of the IN.PACT Admiral Drug-Coated Balloon (DCB) is expected to boost the top line.
Haemonetics' Plasma Momentum Solid, Margins Gain Traction
by Zacks Equity Research
Solid end-market demand for plasma-derived biopharmaceuticals continues to drive growth for Haemonetics (HAE).
ISRG or ITGR: Which is a Better Medical Instrument Stock?
by Zacks Equity Research
Intuitive Surgical (ISRG) and Integer Holdings' (ITGR) strong fundamentals and rising share price make them close contenders.